|
Model Number UNKNOWN |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Hyphema (1911); Intraocular Pressure Decreased (4468)
|
Event Date 04/14/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Age (mos): at disease onset: = 1: 54; 1-6: 15; 6-12: 0; 12+: 6; at time of vco1tbo: = 1: 0;1-6: 41; 6-12: 19; 12+: 15.Date of event: (b)(6) 2022.The date article published online.Implant date: n/a.Healon is not an implantable device.Explant date: n/a.Healon is not an implantable device; therefore, not explanted.Device manufacture date: unknown, as the lot number was not provided.Device evaluation: the healon units were not returned for evaluation.Therefore, a failure analysis of the complaint device could not be performed.The reported complaint cannot be confirmed.Manufacturing record evaluation: the manufacturing records for the healon could not be reviewed as no lot details were provided.A historical review cannot be performed since the lot number is unknown.Conclusion: no sample was returned, and the lot number is unknown, an investigation could not be performed, and no malfunction is confirmed.Citation: vahedian, z.; fakhraie, g.; hussein ahmed, a., viscocanalostomy combined with trabeculotomy for management of refractory primary congenital glaucoma american association for pediatric ophthalmology and strabismus.2022;26:121.Pp.1-6 all pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
|
Event Description
|
The following article was received based on a literature review: article: viscocanalostomy combined with trabeculotomy for management of refractory primary congenital glaucoma.A prospective study was done to investigate the outcome of viscocanalostomy combined with trabeculotomy (vco+tbo) in primary congenital glaucoma (pcg) with history of failed trabeculotomy.A total of 46 patients (n=75 eyes) were enrolled in the study.The procedure included a deep scleral flap incision, wherein high-molecular-weight sodium hyaluronate (healon gv, pfizer, new york, ny) was injected into the ostia of schlemm¿s canal using a 30-gauge cannula.After trabeculotomy, the superficial scleral flap and conjunctiva were then tightly sutured back using 8-0 polyglactin 910 sutures.Finally, the anterior chamber was irrigated and reformed with balanced salt solution.Reported complication included hyphema (b)(4) eyes) which resolved spontaneously in all cases.At the last follow-up, there were failures (n= 31 eyes); one failure, which was due to hypotony caused by formation of iatrogenic cyclodialysis (b)(4) eye) which was repaired surgically after 1 month of treatment with cycloplegic agents.There were no further interventions reported.
|
|
Search Alerts/Recalls
|
|
|